REFERENCES
- Nowak-Gottl U, Kosch A, Schlegel N. Thromboembolism in newborns, infants and children. Thromb Haemost. 2001; 86: 464–474
- Freeze HH, Aebi M. Altered glycan structures: The molecular basis of congenital disorders of glycosylation. Curr Opin Struct Biol. 2005; 15: 490–498
- Jaeken J, Matthijs G. Congenital disorders of glycosylation: A rapidly expanding disease family. Annu Rev Genomics Hum Genet. 2007; 8: 261–278
- Grunewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: A review. Pediatr Res. 2002; 52: 618–624
- Niehues R, Hasilik M, Alton G, et al. Carbohydrate-deficient glycoprotein syndrome type Ib: Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest. 1998; 101: 1414–1420
- Jaeken J, Matthijs G, Saudubray JM, et al. Phosphomannose isomerase deficiency: A carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet. 1998; 62: 1535–1539
- Babovic-Vuksanovic D, Patterson MC, Schwenk WF, et al. Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome. J Pediatr. 1999; 135: 775–781
- De Lonlay P, Cuer M, Vuillaumier-Barrot S, et al. Hyperinsulinemic hypoglycemia as a presenting sign in phosphomannose isomerase deficiency: A new manifestation of carbohydrate-deficient glycoprotein syndrome treatable with mannose. J Pediatr. 1999; 135: 379–383
- De Lonlay P, Seta N, Barrot S, et al. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: A series of 26 cases. J Med Genet. 2001; 38: 14–19
- Westphal V, Kjaergaard S, Davis JA, Peterson SM, Skovby F, Freeze HH. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: Long-term outcome and effects of mannose supplementation. Mol Genet Metab. 2001; 73: 77–85
- Van Geet C, Jaeken J, Freson K, et al. Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications. J Inherit Metab Dis. 2001; 24: 477–492
- Van Geet C, Jaeken J. A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome. Pediatr Res. 1993; 33: 540–541
- Young G, Driscoll MC. Coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome: Case report and review of the literature. Am J Hematol. 1999; 60: 66–69
- Fiumara A, Barone R, Buttitta P, et al. Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type I. Thromb Haemost. 1996; 76: 502–504
- Esmon CT. Crosstalk between inflammation and thrombosis. Maturitas. 2004; 47: 305–314
- Harms HK, Zimmer KP, Kurnik K, Bertele-Harms RM, Weidinger S, Reiter K. Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. Acta Paediatr. 2002; 91: 1065–1072